The global acyl CoA desaturase market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). An increase in the number of chronic diseases leads to more focus on preventive health measures. Increased awareness and consumer demand for healthy eating and the health benefits of acyl Coa disaster drive the market growth. New production technologies and the need for essential fatty acids in food and beverages, children's formula, and medicine are also fueling the market. In addition, the fatty acids acyl chain results in unsaturated fatty acids that play an important role in plant development and are responsive to biotic and abiotic stresses. Wheat germ oil the most important wheat product can be another good alternative for edible oils with clinical advantages due to the high amount of unsaturated fatty acids.
Browse the full report of " Global Acyl CoA Desaturase Market Size, Share & Trends Analysis Report by Type (Aramchol, T-3764518, TSN-2898, and Others), and by Application (Acne Vulgaris, Colorectal Cancer, Liver Fibrosis, Metastatic Renal Cell Carcinoma, and Others) Forecast (2022-2028)" at https://www.omrglobal.com/industry-reports/acyl-coa-desaturase-market
Market Coverage
Segment Covered-
Regions Covered-
Competitive Landscape- including Daiichi Sankyo Co. Ltd., GlaxoSmithKline plc, Novartis International AG, and others.
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Acyl CoA Desaturase Market Report Segment
By Type
By Application
Global Acyl CoA Desaturase Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World